1. Home
  2. TS vs RMD Comparison

TS vs RMD Comparison

Compare TS & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tenaris S.A.

TS

Tenaris S.A.

HOLD

Current Price

$59.75

Market Cap

29.8B

Sector

Industrials

ML Signal

HOLD

Logo ResMed Inc.

RMD

ResMed Inc.

HOLD

Current Price

$206.92

Market Cap

32.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TS
RMD
Founded
2001
1989
Country
Luxembourg
United States
Employees
24875
10600
Industry
Steel/Iron Ore
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.8B
32.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TS
RMD
Price
$59.75
$206.92
Analyst Decision
Buy
Buy
Analyst Count
5
10
Target Price
$58.80
$292.56
AVG Volume (30 Days)
1.9M
1.2M
Earning Date
05-06-2026
04-30-2026
Dividend Yield
2.80%
1.13%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$1.53
$10.60
Revenue Next Year
$3.59
$7.41
P/E Ratio
$12.59
$25.61
Revenue Growth
N/A
N/A
52 Week Low
$32.00
$198.64
52 Week High
$64.33
$293.81

Technical Indicators

Market Signals
Indicator
TS
RMD
Relative Strength Index (RSI) 46.81 32.97
Support Level $56.88 $198.64
Resistance Level $60.01 $260.21
Average True Range (ATR) 0.99 5.39
MACD -0.56 -0.69
Stochastic Oscillator 30.05 28.51

Price Performance

Historical Comparison
TS
RMD

About TS Tenaris S.A.

Tenaris SA is engaged in the manufacture and supply of steel pipe products and related services for the energy industry and other industrial applications. The company has one reportable segment, Tubes, which includes the production and sale of steel tubular products such as OCTG, line pipe, and mechanical and structural tubes, mainly for the oil and gas industry. It operates an integrated network of manufacturing, research, and service facilities across the Americas, Europe, the Middle East, Asia, and Africa.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Share on Social Networks: